Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 70 entries
Sorted by: Best Match Show Resources per page
Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study.

Annals of surgery

Markar SR, Zaninotto G, Castoro C, Johar A, Lagergren P, Elliott JA, Gisbertz SS, Mariette C, Alfieri R, Huddy J, Sounderajah V, Pinto E, Scarpa M, Klevebro F, Sunde B, Murphy CF, Greene C, Ravi N, Piessen G, Brenkman H, Ruurda JP, Van Hillegersberg R, Lagarde S, Wijnhoven B, Pera M, Roig J, Castro S, Matthijsen R, Findlay J, Antonowicz S, Maynard N, McCormack O, Ariyarathenam A, Sanders G, Cheong E, Jaunoo S, Allum W, Van Lanschot J, Nilsson M, Reynolds JV, van Berge Henegouwen MI, Hanna GB.
PMID: 32404661
Ann Surg. 2020 Nov 17; doi: 10.1097/SLA.0000000000003917. Epub 2020 Nov 17.

OBJECTIVE: To identify the most prevalent symptoms and those with greatest impact upon health-related quality of life (HRQOL) among esophageal cancer survivors.BACKGROUND: Long-term symptom burden after esophagectomy, and associations with HRQOL, are poorly understood.PATIENTS AND METHODS: Between 2010 and...

Cite
Markar SR, Zaninotto G, Castoro C, et al. Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study. Ann Surg. 2020;doi: 10.1097/SLA.0000000000003917.
Markar, S. R., Zaninotto, G., Castoro, C., Johar, A., Lagergren, P., Elliott, J. A., Gisbertz, S. S., Mariette, C., Alfieri, R., Huddy, J., Sounderajah, V., Pinto, E., Scarpa, M., Klevebro, F., Sunde, B., Murphy, C. F., Greene, C., Ravi, N., Piessen, G., Brenkman, H., Ruurda, J. P., Van Hillegersberg, R., Lagarde, S., Wijnhoven, B., Pera, M., Roig, J., Castro, S., Matthijsen, R., Findlay, J., Antonowicz, S., Maynard, N., McCormack, O., Ariyarathenam, A., Sanders, G., Cheong, E., Jaunoo, S., Allum, W., Van Lanschot, J., Nilsson, M., Reynolds, J. V., van Berge Henegouwen, M. I., & Hanna, G. B. (2020). Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study. Annals of surgery, . https://doi.org/10.1097/SLA.0000000000003917
Markar, Sheraz R, et al. "Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study." Annals of surgery vol. (2020). doi: https://doi.org/10.1097/SLA.0000000000003917
Markar SR, Zaninotto G, Castoro C, Johar A, Lagergren P, Elliott JA, Gisbertz SS, Mariette C, Alfieri R, Huddy J, Sounderajah V, Pinto E, Scarpa M, Klevebro F, Sunde B, Murphy CF, Greene C, Ravi N, Piessen G, Brenkman H, Ruurda JP, Van Hillegersberg R, Lagarde S, Wijnhoven B, Pera M, Roig J, Castro S, Matthijsen R, Findlay J, Antonowicz S, Maynard N, McCormack O, Ariyarathenam A, Sanders G, Cheong E, Jaunoo S, Allum W, Van Lanschot J, Nilsson M, Reynolds JV, van Berge Henegouwen MI, Hanna GB. Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study. Ann Surg. 2020 Nov 17; doi: 10.1097/SLA.0000000000003917. Epub 2020 Nov 17. PMID: 32404661.
Copy Download .nbib Format: NLM
Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Kalff MC, Wagner AD, Verhoeven RHA, Lemmens VEPP, van Laarhoven HWM, Gisbertz SS, van Berge Henegouwen MI.
PMID: 34365540
Gastric Cancer. 2021 Aug 07; doi: 10.1007/s10120-021-01225-1. Epub 2021 Aug 07.

BACKGROUND: Sex differences in clinicopathological characteristics, treatment, and postoperative outcomes of gastric and esophageal cancer are largely undefined. This study aimed to compare tumor and treatment characteristics and outcomes of gastric and esophageal cancer surgery between male and female...

Cite
Kalff MC, Wagner AD, Verhoeven RHA, et al. Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit. Gastric Cancer. 2021;doi: 10.1007/s10120-021-01225-1.
Kalff, M. C., Wagner, A. D., Verhoeven, R. H. A., Lemmens, V. E. P. P., van Laarhoven, H. W. M., Gisbertz, S. S., van Berge Henegouwen, M. I. (2021). Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, . https://doi.org/10.1007/s10120-021-01225-1
Kalff, Marianne C, et al. "Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit." Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association vol. (2021). doi: https://doi.org/10.1007/s10120-021-01225-1
Kalff MC, Wagner AD, Verhoeven RHA, Lemmens VEPP, van Laarhoven HWM, Gisbertz SS, van Berge Henegouwen MI. Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit. Gastric Cancer. 2021 Aug 07; doi: 10.1007/s10120-021-01225-1. Epub 2021 Aug 07. PMID: 34365540.
Copy Download .nbib Format: NLM
Surgical Therapy of Esophageal Adenocarcinoma-Current Standards and Future Perspectives.

Cancers

Schröder W, Gisbertz SS, Voeten DM, Gutschow CA, Fuchs HF, van Berge Henegouwen MI.
PMID: 34830988
Cancers (Basel). 2021 Nov 21;13(22). doi: 10.3390/cancers13225834.

Transthoracic esophagectomy is currently the predominant curative treatment option for resectable esophageal adenocarcinoma. The majority of carcinomas present as locally advanced tumors requiring multimodal strategies with either neoadjuvant chemoradiotherapy or perioperative chemotherapy alone. Minimally invasive, including robotic, techniques are...

Cite
Schröder W, Gisbertz SS, Voeten DM, et al. Surgical Therapy of Esophageal Adenocarcinoma-Current Standards and Future Perspectives. Cancers (Basel). 2021;13(22)doi: 10.3390/cancers13225834.
Schröder, W., Gisbertz, S. S., Voeten, D. M., Gutschow, C. A., Fuchs, H. F., & van Berge Henegouwen, M. I. (2021). Surgical Therapy of Esophageal Adenocarcinoma-Current Standards and Future Perspectives. Cancers, 13(22), . https://doi.org/10.3390/cancers13225834
Schröder, Wolfgang, et al. "Surgical Therapy of Esophageal Adenocarcinoma-Current Standards and Future Perspectives." Cancers vol. 13,22 (2021). doi: https://doi.org/10.3390/cancers13225834
Schröder W, Gisbertz SS, Voeten DM, Gutschow CA, Fuchs HF, van Berge Henegouwen MI. Surgical Therapy of Esophageal Adenocarcinoma-Current Standards and Future Perspectives. Cancers (Basel). 2021 Nov 21;13(22). doi: 10.3390/cancers13225834. PMID: 34830988; PMCID: PMC8616112.
Copy Download .nbib Format: NLM
The extent of lymphadenectomy in esophageal resection for cancer should be standardized.

Journal of thoracic disease

Hagens ERC, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS.
PMID: 28815067
J Thorac Dis. 2017 Jul;9:S713-S723. doi: 10.21037/jtd.2017.07.42.

The incidence of esophageal cancer increases, with approximately 482,000 patients diagnosed with esophageal cancer each year. Despite the growing incidence of esophageal carcinoma, the extent of the lymphadenectomy is still under discussion. Lymph node status is an important prognostic...

Cite
Hagens ERC, van Berge Henegouwen MI, Cuesta MA, et al. The extent of lymphadenectomy in esophageal resection for cancer should be standardized. J Thorac Dis. 2017;9:S713-S723doi: 10.21037/jtd.2017.07.42.
Hagens, E. R. C., van Berge Henegouwen, M. I., Cuesta, M. A., & Gisbertz, S. S. (2017). The extent of lymphadenectomy in esophageal resection for cancer should be standardized. Journal of thoracic disease, 9S713-S723. https://doi.org/10.21037/jtd.2017.07.42
Hagens, Eliza R C, et al. "The extent of lymphadenectomy in esophageal resection for cancer should be standardized." Journal of thoracic disease vol. 9 (2017): S713-S723. doi: https://doi.org/10.21037/jtd.2017.07.42
Hagens ERC, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS. The extent of lymphadenectomy in esophageal resection for cancer should be standardized. J Thorac Dis. 2017 Jul;9:S713-S723. doi: 10.21037/jtd.2017.07.42. PMID: 28815067; PMCID: PMC5538989.
Copy Download .nbib Format: NLM
Correction to: Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

van der Wielen N, Straatman J, Daams F, Rosati R, Parise P, Weitz J, Reissfelder C, Diez Del Val I, Loureiro C, Parada-González P, Pintos-Martínez E, Mateo Vallejo F, Medina Achirica C, Sánchez-Pernaute A, Ruano Campos A, Bonavina L, Asti ELG, Alonso Poza A, Gilsanz C, Nilsson M, Lindblad M, Gisbertz SS, van Berge Henegouwen MI, Fumagalli Romario U, De Pascale S, Akhtar K, Jaap Bonjer H, Cuesta MA, van der Peet DL.
PMID: 32970265
Gastric Cancer. 2021 Jan;24(1):272. doi: 10.1007/s10120-020-01122-z.

No abstract available.

Cite
van der Wielen N, Straatman J, Daams F, et al. Correction to: Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial. Gastric Cancer. 2021;24(1):272doi: 10.1007/s10120-020-01122-z.
van der Wielen, N., Straatman, J., Daams, F., Rosati, R., Parise, P., Weitz, J., Reissfelder, C., Diez Del Val, I., Loureiro, C., Parada-González, P., Pintos-Martínez, E., Mateo Vallejo, F., Medina Achirica, C., Sánchez-Pernaute, A., Ruano Campos, A., Bonavina, L., Asti, E. L. G., Alonso Poza, A., Gilsanz, C., Nilsson, M., Lindblad, M., Gisbertz, S. S., van Berge Henegouwen, M. I., Fumagalli Romario, U., De Pascale, S., Akhtar, K., Jaap Bonjer, H., Cuesta, M. A., & van der Peet, D. L. (2021). Correction to: Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 24(1), 272. https://doi.org/10.1007/s10120-020-01122-z
van der Wielen, Nicole, et al. "Correction to: Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial." Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association vol. 24,1 (2021): 272. doi: https://doi.org/10.1007/s10120-020-01122-z
van der Wielen N, Straatman J, Daams F, Rosati R, Parise P, Weitz J, Reissfelder C, Diez Del Val I, Loureiro C, Parada-González P, Pintos-Martínez E, Mateo Vallejo F, Medina Achirica C, Sánchez-Pernaute A, Ruano Campos A, Bonavina L, Asti ELG, Alonso Poza A, Gilsanz C, Nilsson M, Lindblad M, Gisbertz SS, van Berge Henegouwen MI, Fumagalli Romario U, De Pascale S, Akhtar K, Jaap Bonjer H, Cuesta MA, van der Peet DL. Correction to: Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial. Gastric Cancer. 2021 Jan;24(1):272. doi: 10.1007/s10120-020-01122-z. PMID: 32970265; PMCID: PMC7852846.
Copy Download .nbib Format: NLM
A more restrictive use of quinolones in patients with community acquired pneumonia is urgently needed.

The Netherlands journal of medicine

Van Berge Henegouwen JM, Groeneveld GH, de Boer MGJ, Visser LG.
PMID: 29256421
Neth J Med. 2017 Dec;75(10):462-463.

No abstract available.

Cite
Van Berge Henegouwen JM, Groeneveld GH, de Boer MGJ, et al. A more restrictive use of quinolones in patients with community acquired pneumonia is urgently needed. Neth J Med. 2017;75(10):462-463
Van Berge Henegouwen, J. M., Groeneveld, G. H., de Boer, M. G. J., & Visser, L. G. (2017). A more restrictive use of quinolones in patients with community acquired pneumonia is urgently needed. The Netherlands journal of medicine, 75(10), 462-463.
Van Berge Henegouwen, J M, et al. "A more restrictive use of quinolones in patients with community acquired pneumonia is urgently needed." The Netherlands journal of medicine vol. 75,10 (2017): 462-463.
Van Berge Henegouwen JM, Groeneveld GH, de Boer MGJ, Visser LG. A more restrictive use of quinolones in patients with community acquired pneumonia is urgently needed. Neth J Med. 2017 Dec;75(10):462-463. PMID: 29256421.
Copy Download .nbib Format: NLM
Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma.

Journal of carcinogenesis

van Nistelrooij AM, van der Korput HA, Broer L, van Marion R, van Berge Henegouwen MI, van Noesel CJ, Biermann K, Spaander MC, Tilanus HW, van Lanschot JJ, Hofman A, Uitterlinden AG, Wijnhoven BP, Dinjens WN.
PMID: 26085818
J Carcinog. 2015 May 21;14:5. doi: 10.4103/1477-3163.157441. eCollection 2015.

OBJECTIVE: Recently, single nucleotide polymorphisms (SNPs) associated with esophageal adenocarcinoma (EAC) and Barrett's esophagus (BE) were identified; rs10419226 (CRTC1), rs11789015 (BARX1), rs2687201 (FOXP1), rs2178146 (FOXF1), rs3111601 (FOXF1), and rs9936833 (FOXF1). These findings indicate that genetic susceptibility could play a...

Cite
van Nistelrooij AM, van der Korput HA, Broer L, et al. Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma. J Carcinog. 2015;14:5doi: 10.4103/1477-3163.157441.
van Nistelrooij, A. M., van der Korput, H. A., Broer, L., van Marion, R., van Berge Henegouwen, M. I., van Noesel, C. J., Biermann, K., Spaander, M. C., Tilanus, H. W., van Lanschot, J. J., Hofman, A., Uitterlinden, A. G., Wijnhoven, B. P., & Dinjens, W. N. (2015). Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma. Journal of carcinogenesis, 145. https://doi.org/10.4103/1477-3163.157441
van Nistelrooij, Anna M J, et al. "Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma." Journal of carcinogenesis vol. 14 (2015): 5. doi: https://doi.org/10.4103/1477-3163.157441
van Nistelrooij AM, van der Korput HA, Broer L, van Marion R, van Berge Henegouwen MI, van Noesel CJ, Biermann K, Spaander MC, Tilanus HW, van Lanschot JJ, Hofman A, Uitterlinden AG, Wijnhoven BP, Dinjens WN. Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma. J Carcinog. 2015 May 21;14:5. doi: 10.4103/1477-3163.157441. eCollection 2015. PMID: 26085818; PMCID: PMC4453126.
Copy Download .nbib Format: NLM
Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study.

Journal of the National Cancer Institute

Dijksterhuis WPM, Kalff MC, Wagner AD, Verhoeven RHA, Lemmens VEPP, van Oijen MGH, Gisbertz SS, van Berge Henegouwen MI, van Laarhoven HWM.
PMID: 33837791
J Natl Cancer Inst. 2021 Nov 02;113(11):1551-1560. doi: 10.1093/jnci/djab075.

BACKGROUND: Biological sex and gender have been reported to affect incidence and overall survival (OS) of curatively treated gastroesophageal cancer. The aim of this study was to compare palliative treatment allocation and OS between women and men with advanced...

Cite
Dijksterhuis WPM, Kalff MC, Wagner AD, et al. Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study. J Natl Cancer Inst. 2021;113(11):1551-1560doi: 10.1093/jnci/djab075.
Dijksterhuis, W. P. M., Kalff, M. C., Wagner, A. D., Verhoeven, R. H. A., Lemmens, V. E. P. P., van Oijen, M. G. H., Gisbertz, S. S., van Berge Henegouwen, M. I., & van Laarhoven, H. W. M. (2021). Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study. Journal of the National Cancer Institute, 113(11), 1551-1560. https://doi.org/10.1093/jnci/djab075
Dijksterhuis, Willemieke P M, et al. "Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study." Journal of the National Cancer Institute vol. 113,11 (2021): 1551-1560. doi: https://doi.org/10.1093/jnci/djab075
Dijksterhuis WPM, Kalff MC, Wagner AD, Verhoeven RHA, Lemmens VEPP, van Oijen MGH, Gisbertz SS, van Berge Henegouwen MI, van Laarhoven HWM. Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study. J Natl Cancer Inst. 2021 Nov 02;113(11):1551-1560. doi: 10.1093/jnci/djab075. PMID: 33837791; PMCID: PMC8562959.
Copy Download .nbib Format: NLM
Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis.

Journal of thoracic disease

Pirozzolo G, Gisbertz SS, Castoro C, van Berge Henegouwen MI, Scarpa M.
PMID: 31463142
J Thorac Dis. 2019 Jul;11(7):3136-3145. doi: 10.21037/jtd.2019.07.30.

A high preoperative neutrophil-lymphocyte ratio (NLR) has been shown in several studies as a predictor of worse survival in many solid neoplasms, including esophageal cancer, but its impact remains unclear. The goal of this systematic review was to gain...

Cite
Pirozzolo G, Gisbertz SS, Castoro C, et al. Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis. J Thorac Dis. 2019;11(7):3136-3145doi: 10.21037/jtd.2019.07.30.
Pirozzolo, G., Gisbertz, S. S., Castoro, C., van Berge Henegouwen, M. I., & Scarpa, M. (2019). Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis. Journal of thoracic disease, 11(7), 3136-3145. https://doi.org/10.21037/jtd.2019.07.30
Pirozzolo, Giovanni, et al. "Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis." Journal of thoracic disease vol. 11,7 (2019): 3136-3145. doi: https://doi.org/10.21037/jtd.2019.07.30
Pirozzolo G, Gisbertz SS, Castoro C, van Berge Henegouwen MI, Scarpa M. Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis. J Thorac Dis. 2019 Jul;11(7):3136-3145. doi: 10.21037/jtd.2019.07.30. PMID: 31463142; PMCID: PMC6688029.
Copy Download .nbib Format: NLM
Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses.

Annals of surgical oncology

van Kooten RT, Voeten DM, Steyerberg EW, Hartgrink HH, van Berge Henegouwen MI, van Hillegersberg R, Tollenaar RAEM, Wouters MWJM.
PMID: 34482453
Ann Surg Oncol. 2021 Sep 05; doi: 10.1245/s10434-021-10734-3. Epub 2021 Sep 05.

OBJECTIVE: The aim of this study is to identify preoperative patient-related prognostic factors for anastomotic leakage, mortality, and major complications in patients undergoing oncological esophagectomy.BACKGROUND: Esophagectomy is a high-risk procedure with an incidence of major complications around 25% and...

Cite
van Kooten RT, Voeten DM, Steyerberg EW, et al. Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses. Ann Surg Oncol. 2021;doi: 10.1245/s10434-021-10734-3.
van Kooten, R. T., Voeten, D. M., Steyerberg, E. W., Hartgrink, H. H., van Berge Henegouwen, M. I., van Hillegersberg, R., Tollenaar, R. A. E. M., & Wouters, M. W. J. M. (2021). Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses. Annals of surgical oncology, . https://doi.org/10.1245/s10434-021-10734-3
van Kooten, Robert T, et al. "Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses." Annals of surgical oncology vol. (2021). doi: https://doi.org/10.1245/s10434-021-10734-3
van Kooten RT, Voeten DM, Steyerberg EW, Hartgrink HH, van Berge Henegouwen MI, van Hillegersberg R, Tollenaar RAEM, Wouters MWJM. Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses. Ann Surg Oncol. 2021 Sep 05; doi: 10.1245/s10434-021-10734-3. Epub 2021 Sep 05. PMID: 34482453.
Copy Download .nbib Format: NLM
Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study Group.

The British journal of surgery

van der Wilk BJ, Hagens ERC, Eyck BM, Gisbertz SS, van Hillegersberg R, Nafteux P, Schröder W, Nilsson M, Wijnhoven BPL, Lagarde SM, van Berge Henegouwen MI.
PMID: 35024794
Br J Surg. 2022 Jan 13; doi: 10.1093/bjs/znab432. Epub 2022 Jan 13.

BACKGROUND: Large studies comparing totally minimally invasive oesophagectomy (TMIE) with laparoscopically assisted (hybrid) oesophagectomy are lacking. Although randomized trials have compared TMIE invasive with open oesophagectomy, daily clinical practice does not always resemble the results reported in such trials....

Cite
van der Wilk BJ, Hagens ERC, Eyck BM, et al. Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study Group. Br J Surg. 2022;doi: 10.1093/bjs/znab432.
van der Wilk, B. J., Hagens, E. R. C., Eyck, B. M., Gisbertz, S. S., van Hillegersberg, R., Nafteux, P., Schröder, W., Nilsson, M., Wijnhoven, B. P. L., Lagarde, S. M., van Berge Henegouwen, M. I. (2022). Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study Group. The British journal of surgery, . https://doi.org/10.1093/bjs/znab432
van der Wilk, Berend J, et al. "Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study Group." The British journal of surgery vol. (2022). doi: https://doi.org/10.1093/bjs/znab432
van der Wilk BJ, Hagens ERC, Eyck BM, Gisbertz SS, van Hillegersberg R, Nafteux P, Schröder W, Nilsson M, Wijnhoven BPL, Lagarde SM, van Berge Henegouwen MI. Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study Group. Br J Surg. 2022 Jan 13; doi: 10.1093/bjs/znab432. Epub 2022 Jan 13. PMID: 35024794.
Copy Download .nbib Format: NLM
Treating Early Delayed Gastric Tube Emptying after Esophagectomy with Pneumatic Pyloric Dilation.

Digestive surgery

Mertens A, Gooszen J, Fockens P, Voermans R, Gisbertz S, Bredenoord A, van Berge Henegouwen MI.
PMID: 34727541
Dig Surg. 2021 Nov 02;1-6. doi: 10.1159/000519785. Epub 2021 Nov 02.

INTRODUCTION: Endoscopic pneumatic pyloric balloon dilation is a treatment option for early postoperative delayed gastric tube emptying following esophageal resection. This study aimed to determine the safety and effectiveness of endoscopic balloon dilation.METHODS: Between 2015 and 2018, patients with...

Cite
Mertens A, Gooszen J, Fockens P, et al. Treating Early Delayed Gastric Tube Emptying after Esophagectomy with Pneumatic Pyloric Dilation. Dig Surg. 2021;1-6doi: 10.1159/000519785.
Mertens, A., Gooszen, J., Fockens, P., Voermans, R., Gisbertz, S., Bredenoord, A., & van Berge Henegouwen, M. I. (2021). Treating Early Delayed Gastric Tube Emptying after Esophagectomy with Pneumatic Pyloric Dilation. Digestive surgery, 1-6. https://doi.org/10.1159/000519785
Mertens, Alexander, et al. "Treating Early Delayed Gastric Tube Emptying after Esophagectomy with Pneumatic Pyloric Dilation." Digestive surgery vol. (2021): 1-6. doi: https://doi.org/10.1159/000519785
Mertens A, Gooszen J, Fockens P, Voermans R, Gisbertz S, Bredenoord A, van Berge Henegouwen MI. Treating Early Delayed Gastric Tube Emptying after Esophagectomy with Pneumatic Pyloric Dilation. Dig Surg. 2021 Nov 02;1-6. doi: 10.1159/000519785. Epub 2021 Nov 02. PMID: 34727541.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 70 entries